Novavax vaccine is nearing approval

A new statement from the European Medicines Agency (EMA) now gives rise to hope. Its director for vaccination strategy, Marco Cavaler, said on Thursday that the corona vaccine from the US manufacturer Novavax, which is one of the protein vaccines, will probably receive approval this year – in other words: in a few days.